Doron Cohen
Director of Finance/CFO chez GALMED PHARMACEUTICALS LTD.
Fortune : 69 $ au 31/03/2024
Profil
Doron Cohen is currently the Chief Financial Officer at Galmed Pharmaceuticals Ltd.
and Onkai, Inc. He previously worked as the Chief Executive Officer at Tangram Strategic Ltd.
and as the Research Director at Gems Investment Research Ltd.
He also served as the Director-Public Relations at World Union of Jewish Students.
Mr. Cohen holds a graduate degree from Boston University and an undergraduate degree from The University of New South Wales.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
27/03/2024 | 200 ( 0,01% ) | 69 $ | 31/03/2024 |
Postes actifs de Doron Cohen
Sociétés | Poste | Début |
---|---|---|
GALMED PHARMACEUTICALS LTD. | Director of Finance/CFO | 01/02/2022 |
Onkai, Inc.
Onkai, Inc. Packaged SoftwareTechnology Services Onkai, Inc. develops a platform that helps local healthcare professionals. The private company is located in the US. | Director of Finance/CFO | 01/10/2023 |
Anciens postes connus de Doron Cohen
Sociétés | Poste | Fin |
---|---|---|
Gems Investment Research Ltd. | Corporate Officer/Principal | 01/01/2017 |
Tangram Strategic Ltd. | Chief Executive Officer | - |
Formation de Doron Cohen
Boston University | Graduate Degree |
The University of New South Wales | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GALMED PHARMACEUTICALS LTD. | Health Technology |
Entreprise privées | 3 |
---|---|
Onkai, Inc.
Onkai, Inc. Packaged SoftwareTechnology Services Onkai, Inc. develops a platform that helps local healthcare professionals. The private company is located in the US. | Technology Services |
Tangram Strategic Ltd. | |
Gems Investment Research Ltd. |